About the Company
homology medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $FIXX News
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced the completion of its ...
FIXX Homology Medicines, Inc.
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases in the United States. The company offers proprietary ...
Homology Medicines Announces Upcoming Merger with Q32 Bio
Homology Medicines Inc (FIXX) has released an update to notify the public and investors about a regulation fd disclosure.
QTTB Homology Medicines, Inc.
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
New Suit - Securities
Homology Medicines and the company's board of directors were hit with a shareholder lawsuit on Feb. 22 in Delaware District Court over the company's proposed acquisition by Q32 Bio. The court ...
Homology Medicines Declares Distribution to Common Stockholders
BEDFORD, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: FIXX) today announced that it declared a distribution to its common stockholders of record as of the close of business on March 21, 2024 of ...
Homology Medicines, Inc.: Homology Medicines Declares Distribution to Common Stockholders
Homology Medicines, Inc. (Nasdaq: FIXX) today announced that it declared a distribution to its common stockholders of record as of the close of business ...
Homology Medicines Inc FIXX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Homology Medicines Inc (FIXX)
Read the Homology Medicines Inc company profile to learn more about the business and the management team. View Homology Medicines Inc facts about employee data, company products and services, and ...
Homology Medicines Inc (FIXX)
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced that the FDA has granted the company Investigational New Drug status for its gene therapy candidate, BMN 307 in ...
Loading the latest forecasts...